Vir Biotechnology (MEX:VIR) Tariff Resilience Score: 8/10 (As of Aug. 19, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:VIR Vir Biotechnology Inc MEX:VIR
52 GF Score
Price MXN170.00
GF Value MXN764.28
! 5 Warning Signs
View Full Analysis

What is Vir Biotechnology Tariff Resilience Score?

Vir Biotechnology MEX:VIR 52 Tariff Resilience Score is 8 as of Aug. 19, 2026. GuruFocus rates MEX:VIR with a GF Score™ of 52/100 and a GF Value™ of MXN764.28. The stock has 5 warning signs investors should review. Among 1,362 Biotechnology companies, Vir Biotechnology ranks better than 98.68% on this metric.

Vir Biotechnology has the Tariff Resilience Score of 8, which implies that the company might have Highly Resilient.

Vir Biotechnology has Vir Biotechnology has high resilience to tariffs due to its focus on biopharmaceuticals, which are often exempt from tariffs. Its global partnerships and diverse supply chain further mitigate risks, and the company has strong pricing power in its niche market.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Vir Biotechnology might have Highly Resilient.

Vir Biotechnology  (MEX:VIR) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Vir Biotechnology Tariff Resilience Score Related Terms

MEX:VIR vs AVBP, XNCR, SEPN: Tariff Resilience Score Comparison

For the Biotechnology subindustry, Vir Biotechnology's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vir Biotechnology Tariff Resilience Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vir Biotechnology's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Vir Biotechnology's Tariff Resilience Score falls into.


MEX:VIR
52GF Score
Vir Biotechnology Inc MEX:VIR
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 8 mean?
Vir Biotechnology (MEX:VIR) has a Tariff Resilience Score of 8 as of Aug. 19, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Vir Biotechnology ranks #18 out of 1362 companies in the Biotechnology industry, placing it in the top 1.3%.
Is Vir Biotechnology's Tariff Resilience Score too high?
Vir Biotechnology's current Tariff Resilience Score is 8. The Biotechnology industry median Tariff Resilience Score is 4.00. Vir Biotechnology's value of 8 is 100% above this industry median. Based on the distribution chart, Vir Biotechnology ranks #18 out of 1362 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Vir Biotechnology has a GF Score™ of 52/100, reflecting its overall financial health beyond just this single metric.
How does Vir Biotechnology's Tariff Resilience Score compare to AVBP and XNCR?
According to the Biotechnology industry distribution chart, Vir Biotechnology ranks #18 out of 1362 companies for Tariff Resilience Score. This places Vir Biotechnology in the top 1% of its industry — outperforming the majority of peers. The industry median Tariff Resilience Score is 4.00. Vir Biotechnology's value of 8 is 100% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Biotechnology company?
The median Tariff Resilience Score among Biotechnology companies is 4.00, based on 1,362 companies in the industry. Companies in the top quartile (top 25%) have a Tariff Resilience Score significantly above this median, while those in the bottom quartile fall well below. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vir Biotechnology's current Tariff Resilience Score of 8 is 100% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. For the Biotechnology industry, the median Tariff Resilience Score is 4.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vir Biotechnology's current Tariff Resilience Score is 8. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vir Biotechnology stock overvalued right now?
Vir Biotechnology (MEX:VIR) has a current Tariff Resilience Score of 8. The stock's GF Value™ is MXN764.28, compared to a current price of MXN170.00 — trading 77.8% below its estimated fair value. The current Tariff Resilience Score is 8 and 100% above the Biotechnology industry median of 4.00. Vir Biotechnology's overall GF Score™ is 52/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Vir Biotechnology (MEX:VIR), the current Tariff Resilience Score is 8 as of Aug. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vir Biotechnology (MEX:VIR) Overvalued in 2026?

Based on GuruFocus' analysis, Vir Biotechnology stock appears to be undervalued. The current stock price of MXN170.00 is trading 77.8% below its estimated GF Value™ of MXN764.28.

Key valuation signals for MEX:VIR:

  • Tariff Resilience Score: 8
  • GF Value™: MXN764.28 vs. price of MXN170.00 (77.8% below fair value)
  • GF Score™: 52/100 with 5 warning signs
  • Industry Position: 100% above the Biotechnology median (#18 of 1362)

No single metric tells the full story. See the MEX:VIR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vir Biotechnology Business Description

Other Exchanges VIR:USA
Address 1800 Owens Street, Suite 900, San Francisco, CA, USA, 94158
Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.
52GF Score

Get the complete analysis for MEX:VIR

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN170.00
Price
MXN764.28
GF Value